You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 101 No. 1, January 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vitiligo and Pernicious Anemia

Inger Grunnet, MD; Jette Howitz, MD; Flemming Reymann, MD; Michael Schwartz, MD

Arch Dermatol. 1970;101(1):82-85.


Abstract

The incidence of vitiligo in the Danish population was determined to be a little above 1% (1.44%), from the examination of a total of 691 admissions during one day of November 1968 to the Glostrup Hospital.

We have tried to clarify the correlation between vitiligo and pernicious anemia by studying more comprehensive series of patients.

Among 84 patients with pernicious anemia, a total of nine cases (10.6%) were found.

Out of 135 patients with vitiligo, five had pernicious anemia (3.7%), while, in the Danish general population, an incidence of pernicious anemia of 0.13% is reported.

It is concluded that such a pronounced relationship may support the theory that vitiligo belongs to the group of autoimmune disorders.



Author Affiliations

Copenhagen

From the Department of Dermatology, the Finsen Institute, and the Department of Medicine, the Copenhagen County Hospital in Glostrup, Copenhagen.


Footnotes

Accepted for publication July 26, 1969.

Reprint requests to Department of Dermatology, The Finsen Institute, 49, Strandboulevard, 2100 Copenhagen (Dr. Reymann).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Leopard Vitiligo
Bhargava
Arch Dermatol 1986;122:378-379.
ABSTRACT  

Autoantibodies and Their Clinical Significance in a Black Vitiligo Population
Grimes et al.
Arch Dermatol 1983;119:300-303.
ABSTRACT  

Antibodies to Melanocytes: Occurrence in Patients With Vitiligo and Chronic Mucocutaneous Candidiasis
Howanitz et al.
Arch Dermatol 1981;117:705-708.
ABSTRACT  

Vitiligo: Clinical Picture and Pathogenesis
McBurney
Arch Intern Med 1979;139:1295-1297.
ABSTRACT  

Vitiligo in a Black Population
Barsky et al.
Arch Dermatol 1979;115:225-225.
ABSTRACT  

Uveitis, Poliosis, Hypomelanosis, and Alopecia in a Patient With Malignant Melanoma
Sober and Haynes
Arch Dermatol 1978;114:439-441.
ABSTRACT  

Prevalence of Vitiligo: Epidemiological Survey on the Isle of Bornholm, Denmark
Howitz et al.
Arch Dermatol 1977;113:47-52.
ABSTRACT  

Vitiligo Associated With Regional Enteritis
Monroe
Arch Dermatol 1976;112:833-834.
ABSTRACT  

The Transcription Factors SOX9 and SOX10 Are Vitiligo Autoantigens in Autoimmune Polyendocrine Syndrome Type I
Hedstrand et al.
J. Biol. Chem. 2001;276:35390-35395.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.